RETN and metabolic dysfunction-associated steatotic liver disease: Circulating resistin levels are increased in patients with NAFLD and NASH, and circulating resistin levels in patients with NAFLD are related to the severity of steatosis, inflammation, and fibrosis [202,242,243].